AMPK alpha 1 (PRKAA1) Human shRNA Plasmid Kit (Locus ID 5562)
CAT#: TG320461
PRKAA1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | AMPK alpha 1 (PRKAA1) Human shRNA Plasmid Kit (Locus ID 5562) |
Locus ID | 5562 |
UniProt ID | Q13131 |
Synonyms | AMPK; AMPKa1; AMPK alpha 1 |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | PRKAA1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 5562). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_006251, NM_206907, NM_001355028, NM_001355029, NM_001355034, NM_001355035, NM_001355036, NM_001355037, NM_006251.1, NM_006251.3, NM_006251.4, NM_006251.5, NM_206907.1, NM_206907.2, NM_206907.3, BC012622, BC037303, BC048980 |
Summary | The protein encoded by this gene belongs to the ser/thr protein kinase family. It is the catalytic subunit of the 5'-prime-AMP-activated protein kinase (AMPK). AMPK is a cellular energy sensor conserved in all eukaryotic cells. The kinase activity of AMPK is activated by the stimuli that increase the cellular AMP/ATP ratio. AMPK regulates the activities of a number of key metabolic enzymes through phosphorylation. It protects cells from stresses that cause ATP depletion by switching off ATP-consuming biosynthetic pathways. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
DHFR/TYMS are positive regulators of glioma cell growth and modulate chemo-sensitivity to temozolomide
,Zhao, M;Tan, B;Dai, X;Shao, Y;He, Q;Yang, B;Wang, J;Weng, Q;,
Eur. J. Pharmacol.
,PubMed ID 31542479
[PRKAA1]
|
Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release from the endoplasmic reticulum by AMP-activated kinase modulators
,Arias-Del-Val, J;Santo-Domingo, J;García-Casas, P;Alvarez-Illera, P;Núñez Galindo, A;Wiederkehr, A;Fonteriz, RI;Montero, M;Alvarez, J;,
Cell Calcium
,PubMed ID 30557841
[PRKAA1]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...